• 1
    Quinlan DJ, McQuillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials. Ann Intern Med 2004; 140: 17583.
  • 2
    Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007; 146: 21122.
  • 3
    Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010; 152: 57889.
  • 4
    Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279: 45862.
  • 5
    Agterof MJ, van Bladel ER, Schutgens RE, Snijder RJ, Tromp EA, Prins MH, Biesma DH. Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration. Thromb Haemost 2009; 102: 6837.
  • 6
    Janjua M, Badshah A, Matta F, Danescu LG, Yaekoub AY, Stein PD. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost 2008; 100: 75661.
  • 7
    Squizzato A, Galli M, Dentali F, Ageno W. Outpatient treatment and early discharge of symptomatic pulmonary embolism: a systematic review. Eur Respir J 2009; 33: 114855.
  • 8
    Otero R, Uresandi F, Jimenez D, Cabezudo MA, Oribe M, Nauffal D, Conget F, Rodríguez C, Cayuela A. Home treatment in pulmonary embolism. Thromb Res 2010; 126: e15.
  • 9
    Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 6924.
  • 10
    Agterof MJ, Schutgens RE, Snijder RJ, Epping G, Peltenburg HG, Posthuma EF, Hardeman JA, van der Griend R, Koster T, Prins MH, Biesma DH. Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level. J Thromb Haemost 2010; 3: 123541.
  • 11
    Beer JH, Burger M, Gretener S, Bernard-Bagattini S, Bounameaux H. Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients. J Thromb Haemost 2003; 1: 1867.
  • 12
    Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW. Matisse investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695702.
  • 13
    Davies CW, Wimperis J, Green ES, Pendry K, Killen J, Mehdi I, Tiplady C, Kesteven P, Rose P, Oldfield W. Early discharge of patients with pulmonary embolism: a two-phase observational study. Eur Respir J 2007; 30: 70814.
  • 14
    Kovacs MJ, Anderson D, Morrow B, Gray L, Touchie D, Wells PS. Outpatient treatment of pulmonary embolism with dalteparin. Thromb Haemost 2000; 83: 20911.
  • 15
    Lim AY, Parr DG, Stableforth DE, Fellows M, Fontaine R, Fegan CD. Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin. Eur J Intern Med 2003; 14: 8993.
  • 16
    Lui B, Tran A, Montalto M. Treatment of patients with pulmonary embolism entirely in hospital in the home. Aust Fam Physician 2007; 36: 3814.
  • 17
    Olsson CG, Bitzen U, Olsson B, Magnusson P, Carlsson MS, Jonson B, Bajc M. Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy. Med Sci Monit 2006; 12: PI913.
  • 18
    Ong BS, Karr MA, Chan DK, Frankel A, Shen Q. Management of pulmonary embolism in the home. Med J Aust 2005; 183: 23942.
  • 19
    Siragusa S, Arcara C, Malato A, Anastasio R, Valerio MR, Fulfaro F, Lo Coco L, Grimaudo S, Bajardi G, Abbadessa V, Gebbia N. Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol 2005; 16: iv1369.
  • 20
    Wells PS, Anderson DR, Rodger MA, Forgie MA, Florack P, Touchie D, Morrow B, Gray L, O’Rourke K, Wells G, Kovacs J, Kovacs MJ. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Arch Intern Med 2005; 165: 7338.
  • 21
    Almahameed A, Carman TL. Outpatient management of stable acute pulmonary embolism: proposed accelerated pathway for risk stratification. Am J Med 2007; 120: S1825.
  • 22
    Donze J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F, Cornuz J, Meyer G, Perrier A, Righini M, Aujesky D. Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008; 100: 9438.
  • 23
    Kucher N, Goldhaber SZ. Risk stratification of acute pulmonary embolism. Semin Thromb Hemost 2006; 32: 83847.
  • 24
    Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 42733.
  • 25
    Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med 2008; 178: 42530.
  • 26
    Moores LK, Holley AB. Computed tomography pulmonary angiography and venography: diagnostic and prognostic properties. Semin Respir Crit Care Med 2008; 29: 314.
  • 27
    Aujesky D, Mazzolai L, Hugli O, Perrier A. Outpatient treatment of pulmonary embolism. Swiss Med Wkly 2009; 139: 68590.
  • 28
    Aujesky D, Smith KJ, Cornuz J, Roberts MS. Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism. Chest 2005; 128: 160110.
  • 29
    Shepperd S, Doll H, Angus RM, Clarke MJ, Iliffe S, Kalra L, Ricauda NA, Wilson AD. Admission avoidance hospital at home. Cochrane Database Syst Rev 2008; CD007491.
  • 30
    WHO. World Health Organization Guidelines on Hand Hygiene in Health Care: A Summary. First Global Patient Safety Challenge. Clean Care is Safe Care. Geneva: World Health Organization, 2009.